Great Point Partners’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-21,322
Closed -$392K 35
2014
Q4
$392K Buy
+21,322
New +$392K 0.19% 27
2014
Q3
Sell
-16,779
Closed -$612K 41
2014
Q2
$612K Sell
16,779
-74,437
-82% -$2.72M 0.27% 35
2014
Q1
$4.18M Sell
91,216
-8,784
-9% -$402K 2.18% 19
2013
Q4
$3.89M Buy
100,000
+60,099
+151% +$2.34M 2.75% 18
2013
Q3
$1.81M Buy
+39,901
New +$1.81M 1.25% 21